EcoDrugPlus

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSAPEG00000013393
Gene Symbol: ALOX5A
1 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSAPEG00000019351
Gene Symbol: ALOX5AP
1 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSAPEG00000019349
Gene Symbol: AVPR1A
1 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSAPEG00000006209
Gene Symbol: AVPR1AB
1 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSAPEG00000000467
Gene Symbol: AVPR2
1 Cross references
210 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSAPEG00000020796
Gene Symbol: AVPR2
1 Cross references
166 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSAPEG00000009393
Gene Symbol: AURKA
1 Cross references
230 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSAPEG00000008030
Gene Symbol: AURKB
1 Cross references
204 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSAPEG00000003753
Gene Symbol: AURKB
1 Cross references
204 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSAPEG00000024241
Gene Symbol: BACE1
1 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSAPEG00000016747
Gene Symbol: BDKRB1
1 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSAPEG00000016674
Gene Symbol: BDKRB2
1 Cross references
230 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).